0 CHECKOUT

PRODUCT FILTERS

REGION

12,646
9,329
9,256
8,606
8,563

COUNTRY

8,177
1,129
507
473
398

CATEGORIES

  • 2,926
  • 2,597
  • 2,224
  • 2,072
  • 2,071
  • 1,879
    • 353
    • 265
    • 257
    • 254
    • 216
    • 209
    • 181
    • 162
    • 160
    • 148
    • 145
    • 136
    • 100
    • 98
  • 1,480
  • 1,414
  • 1,346
  • 1,291
  • 1,278
  • 1,016
  • 1,005
    • 250
  • 936
  • 592
  • 557
  • 514
  • 407
  • 384
    • 406
      • 57
    • 113
  • 378
  • 163
  • 131
SHOW ALL

PRICE

5,279
10,138
16,809
32,372

PUBLISHED

2,185
7,388
15,598
32,372

PRODUCT TYPE

25,447
2,714
2,560
729
530
223
70
42
29
20
6
1
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. Show Less Read more

20s Proteasome Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “20s Proteasome Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the 20s Proteasome Inhibitors. The...

Published:  March 2016
Price:  From

TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2016

SUMMARY The report, “TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and...

Published:  March 2016
Price:  From

TRAIL Receptor Agonists -Pipeline Insights, 2016

SUMMARY The report, “TRAIL Receptor Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the TRAIL Receptor Agonists. The report...

Published:  March 2016
Price:  From

TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists -Pipeline Insights, 2016

SUMMARY The report, “TRAIL Receptor 2 (TRAIL-R2 or Death Receptor 5 or DR5) Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around...

Published:  March 2016
Price:  From

TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights, 2016

SUMMARY The report, “TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around...

Published:  March 2016
Price:  From

Placental Growth Factor (PIGF) Blockers -Pipeline Insights, 2016

SUMMARY The report, “Placental Growth Factor (PIGF) Blockers-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Placental Growth...

Published:  March 2016
Price:  From

Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Wnt Signaling Pathway Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Wnt Signaling Pathway Inhibitors....

Published:  March 2016
Price:  From

Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2016

SUMMARY The report, “Voltage-Dependent Calcium Channel Blockers-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent...

Published:  March 2016
Price:  From

Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers -Pipeline Insights, 2016

SUMMARY The report, “Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the...

Published:  March 2016
Price:  From

Tie-2 Receptor Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Tie-2 Receptor Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tie-2 Receptor Inhibitors. The...

Published:  March 2016
Price:  From

Tie-2 Receptor Agonists -Pipeline Insights, 2016

SUMMARY The report, “Tie-2 Receptor Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tie-2 Receptor Agonists. The report...

Published:  March 2016
Price:  From

Thrombopoietin Receptor (TpoR) Agonists -Pipeline Insights, 2016

SUMMARY The report, “Thrombopoietin Receptor (TpoR) Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Thrombopoietin Receptor...

Published:  March 2016
Price:  From

Voltage-Gated Sodium Channel Blockers -Pipeline Insights, 2016

SUMMARY The report, “Voltage-Gated Sodium Channel Blockers-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Voltage-Gated Sodium...

Published:  March 2016
Price:  From

Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2016

SUMMARY The report, “Voltage-Dependent T-Type Calcium Channel Blockers-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent...

Published:  March 2016
Price:  From

Voltage-Dependent N-Type Calcium Channel Blockers -Pipeline Insights, 2016

SUMMARY The report, “Voltage-Dependent N-Type Calcium Channel Blockers-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent...

Published:  March 2016
Price:  From

TGF-Beta-2 Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “TGF-Beta-2 Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the TGF-Beta-2 Inhibitors. The report covers...

Published:  March 2016
Price:  From

TGF-Beta-1 Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “TGF-Beta-1 Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the TGF-Beta-1 Inhibitors. The report covers...

Published:  March 2016
Price:  From

Tau Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Tau Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tau Inhibitors. The report covers the product...

Published:  March 2016
Price:  From

Selective Serotonin Reuptake Inhibitors (SSRI) -Pipeline Insights, 2016

SUMMARY The report, “Selective Serotonin Reuptake Inhibitors (SSRI)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Selective...

Published:  March 2016
Price:  From

T Cell Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “T Cell Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the T Cell Inhibitors. The report covers the...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients